Laser light shows promise for thinning hair in new trial
NCT ID NCT07588243
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study is testing a device called Ultra that uses low-level laser light to help hair grow back. It involves 44 adults aged 22 to 70 with male or female pattern baldness. Participants will receive six laser treatments on their scalp, two weeks apart, and researchers will check if hair density and thickness improve after 90 days.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Low-level laser therapy device (Ultra)
- What this could lead to
- If successful, this could offer a non-invasive option to improve hair density and thickness for people with common hair loss.
- What could go wrong
- This is a small early study with only 44 participants, so results may not apply to everyone. The treatment requires multiple sessions and may not work for all types of hair loss.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENIC ALOPECIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cynosure Lutronic
RECRUITINGWestford, Massachusetts, 01886, United States
-
Dy Dermatology
RECRUITINGGlenview, Illinois, 60025, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily capsule thicken thinning hair? a trial puts three doses to the test
- Gummy bears for baldness? new study tests sweet solution
- Can tiny needles regrow hair? new study aims to find out
- Hair loss protein target revealed? minoxidil study probes JAK2
- New hair loss gel takes on minoxidil in Head-to-Head trial
- New Triple-Drug hair loss treatment enters final testing phase